These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1494799)

  • 1. [Monitoring of clinical trials and interim analysis. 1. Monitoring committee].
    Boutitie F; Bellissant E; Blanchard J; Boissel JP; Cauquil J; Chauvin F; Derzko G; Ducruet T; Durrleman S; Girre JP
    Therapie; 1992; 47(4):345-9. PubMed ID: 1494799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring of clinical trials and interim analysis. 2. Statistic methods].
    Boutitie F; Bellissant E; Blanchard J; Boissel JP; Cauquil J; Chauvin F; Derzko G; Ducruet T; Durrleman S; Girre JP
    Therapie; 1992; 47(4):351-5. PubMed ID: 1494800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Data and Safety Monitoring Committee (DSMC).
    Wilhelmsen L
    Stat Med; 2002 Oct; 21(19):2823-9. PubMed ID: 12325098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The data monitoring experience in the MOXCON trial.
    Pocock S; Wilhelmsen L; Dickstein K; Francis G; Wittes J
    Eur Heart J; 2004 Nov; 25(22):1974-8. PubMed ID: 15541832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The investigational drug steering committee.
    Ratain MJ
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):779-80. PubMed ID: 17998895
    [No Abstract]   [Full Text] [Related]  

  • 6. Individual patient meta-analysis of self-monitoring of an oral anticoagulation protocol.
    Perera R; Heneghan C; Fitzmaurice D;
    J Heart Valve Dis; 2008 Mar; 17(2):233-8. PubMed ID: 18512497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Workshop on Data Monitoring Committee in NIH"--data monitoring in cancer clinical trial].
    Sakamoto J; Nakazato H
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1099-104. PubMed ID: 1626947
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interim analysis in clinical trials: a methodological guide].
    Muñoz Navarro SR; Bangdiwala SI
    Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The independent statistician for data monitoring committees.
    DeMets DL; Fleming TR
    Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Policies for clinical trials in cancer].
    Suemasu K
    Gan No Rinsho; 1988 Jan; 34(1):7-12. PubMed ID: 3339851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The other side of clinical trial monitoring; assuring data quality and procedural adherence.
    Williams GW
    Clin Trials; 2006; 3(6):530-7. PubMed ID: 17170037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring the safety of participants in randomised clinical trials: basis and methods].
    Tijssen JG
    Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacy Department standard procedures for clinical trial development].
    Pérez Peiró C; Porta Oltra B; Cholvi Llovell M; Jiménez Torres NV
    Farm Hosp; 2004; 28(1):36-47. PubMed ID: 15012177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Futility approaches to interim monitoring by data monitoring committees.
    Demets DL
    Clin Trials; 2006; 3(6):522-9. PubMed ID: 17170036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial.
    Lewis RJ; Berry DA; Cryer H; Fost N; Krome R; Washington GR; Houghton J; Blue JW; Bechhofer R; Cook T; Fisher M
    Ann Emerg Med; 2001 Oct; 38(4):397-404. PubMed ID: 11574796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do clinical trials improve quality of care? A comparison of clinical processes and outcomes in patients in a clinical trial and similar patients outside a trial where both groups are managed according to a strict protocol.
    West J; Wright J; Tuffnell D; Jankowicz D; West R
    Qual Saf Health Care; 2005 Jun; 14(3):175-8. PubMed ID: 15933313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparing the P & T committee agenda for new drug requests.
    Standish RC; Evans PJ; Bell JE
    Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.